Pyrazinamide

吡嗪酰胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePyrazinamide
Drug Alias Name吡嗪醯胺pyrazinamidumpyrazinamide对二氮苯酰胺pirazinamida +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsTuberculosis
Approved Indications in ChinaTuberculosis
Original Approved Country/TerritoryMainland China
Original Approved Date1984/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Guokang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeJ04AK01
Related LinksWikipediaDrugBankKEGG